Non-adherent cell-specific expression of DOCK2, a member of the human CDM-family proteins

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1452, Issue 2, 1999, Pages 179-187

  Nishihara, Hiroshi ^a,b   Kobayashi, Shin ^a   Hashimoto, Yuko ^c   Ohba, Fumiyo ^a   Mochizuki, Naoki ^a   Kurata, Takeshi ^c   Nagashima, Kazuo ^b   Matsuda, Michiyuki ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

CDM family protein; Ced 5; DOCK180; Mbc

Indexed keywords

ADAPTOR PROTEIN; FOCAL ADHESION KINASE; GENE PRODUCT; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CAENORHABDITIS ELEGANS; CELL ADHESION; CELL SPECIFICITY; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; HUMAN; HUMAN CELL; LYMPHOCYTE; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SPLEEN; THYMUS;

AMINO ACID SEQUENCE; CAENORHABDITIS ELEGANS PROTEINS; CARRIER PROTEINS; DNA, COMPLEMENTARY; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-CRK; RAC GTP-BINDING PROTEINS; RAC1 GTP-BINDING PROTEIN; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SPLEEN; THYMUS GLAND;

ANIMALIA; CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; MELANOGASTER;

EID: 0032747430     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(99)00133-0     Document Type: Article

References (28)

1. Kiyokawa E., Mochizuki N., Kurata T., Matsuda M. Role of Crk oncogene product in physiologic signaling. Crit. Rev. Oncog. 8:1997;329-342.
2. Sakai R., Iwamatsu A., Hirano N., Ogawa S., Tanaka T., Mano H., Yazaki Y., Hirai H. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J. 13:1994;3748-3756.
3. Klemke R.L., Leng J., Molander R., Brooks P.C., Vuori K., Cheresh D.A. CAS/Crk coupling serves as a 'molecular switch' for induction of cell migration. J. Cell Biol. 140:1998;961-972.
4. Cas as a mediator of focal adhesion kinase-promoted cell migration. J. Cell Biol. 140:1998;211-221.
5. Dolfi F., Garcia-Guzman M., Ojaniemi M., Nakamura H., Matsuda M., Vuori K. The adapter protein Crk regulates the JNK signaling pathway in response to multiple cellular stimuli. Proc. Natl. Acad. Sci. USA. 95:1998;15394-15399.
6. Zhu T., Goh E.K., Le Roith D., Lobie P.E. Growth hormone stimulates the formation of a multiprotein signaling complex involving p130(Cas) and CrkII. Resultant activation of c-jun n-terminal kinase/stress-activated protein kinase (JNK/SAPK). J. Biol. Chem. 273:1998;33864-33875.
7. Hasegawa H., Kiyokawa E., Tanaka S., Nagashima K., Gotoh N., Shibuya M., Kurata T., Matsuda M. DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the membrane. Mol. Cell. Biol. 16:1996;1770-1776.
8. Kiyokawa E., Hashimoto Y., Kobayashi S., Sugimura H., Kurata T., Matsuda M. Activation of Rac1 by a Crk SH3-binding protein, DOCK180. Genes Dev. 12:1998;3331-3336.
9. Nolan K.M., Barrett K., Hu K.-Q., Lu Y., Settleman J. Myoblast city functions in a Rac-mediated signaling pathway during Drosophila embryogenesis. Genes Dev. 12:1998;3337-3342.
10. Wu Y.C., Horvitz H.R. C. elegans phagocytosis and cell-migration protein CED-5 is similar to human DOCK180. Nature (London). 392:1998;501-504.
11. Erickson M.S., Galletta B.J., Abmayr S.M. Drosophila myoblast city encodes a conserved protein that is essential for myoblast fusion, dorsal closure, and cytoskeletal organization. J. Cell Biol. 138:1997;589-603.
12. Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O., Tanaka A., Kotani H., Miyajima N., Nomura N. Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain. DNA Res. 3:1996;321-354.
13. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:1994;4673-4680.
14. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:1991;193-200.
15. Matsuda M., Tanaka S., Nagata S., Kojima A., Kurata T., Shibuya M. Two species of human CRK cDNA encode proteins with distinct biological activities. Mol. Cell. Biol. 12:1992;3482-3489.
16. Adams J.M., Houston H., Allen J., Lints T., Harvey R. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. Oncogene. 7:1992;611-618.
17. Tanaka M., Gupta R., Mayer B.J. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins. Mol. Cell. Biol. 15:1995;6829-6837.
18. E. Harlow, E. Lane, Antibodies. A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1988.
19. Matsuda M., Nagata S., Tanaka S., Nagashima K., Kurata T. Structural requirement of the CRK SH2 region for the binding to phosphotyrosine-containing proteins: evidence from reactivity to monoclonal antibodies. J. Biol. Chem. 268:1993;4441-4446.
20. Cas complex. J. Biol. Chem. 273:1998;24479-24484.
21. Reichman C.T., Mayer B.J., Keshau S., Hanafusa H. The product of the cellular crk gene consists primarily of SH2 and SH3 regions. Cell Growth Differ. 3:1992;451-460.
22. Crespo P., Schuebel K.E., Ostrom A.A., Gutkind J.S., Bustelo X.R. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature (London). 385:1997;169-172.
23. Tsuchiya S., Kobayashi Y., Goto Y., Okumura H., Nakae S., Konno T., Tada K. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 42:1982;1530-1536.
24. Mackay D.J., Hall A. Rho GTPases. J. Biol. Chem. 273:1998;20685-20688.
25. Abo A., Pick E., Hall A., Totty N., Teahan C.G., Segal A.W. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature (London). 353:1991;668-670.
26. Faris S.L., Rinckel L.A., Huang J., Hong Y.R., Kleinberg M.E. Phagocyte NADPH oxidase p67-phox possesses a novel carboxylterminal binding site for the GTPases Rac2 and Cdc42. Biochem. Biophys. Res. Commun. 247:1998;271-276.
27. Diekmann D., Abo A., Johnston C., Segal A.W., Hall A. Interaction of rac with p67(phox) and regulation of phagocytic NADPH oxidase activity. Science. 265:1994;531-533.
28. Leusen J.H., de Klein A., Hilarius P.M., Ahlin A., Palmblad J., Smith C.I., Diekmann D., Hall A., Verhoeven A.J., Roos D. Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease. J. Exp. Med. 184:1996;1243-1249.